Health Trials

High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

1

Review clinical trials related to High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

This is a multi-part Phase 2 study to evaluate the efficacy and safety of azenosertib (ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Part 2 of the study will be conducted in subjects whose tumors are Cyclin E1 positive as determined by central review using the Sponsor's investigational clinical trial assay.

Participants needed: 310
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, IncUpdated: Jul 1, 2026Locations: 92
Eligibility criteria

Age ≥18 years [+11]

Primary platinum-refractory disease [+23]

Read more